Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Mitochondria as a Cellular Hub in Neurological Disorders"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 9766
Special Issue Editor
E-Mail Website1 Website2
Interests: mitochondrial bioenergetics; oxidative phosphorylation; mitochondrial dysfunction; metabolic regulation; oxidative stress; apoptosis; Alzheimer’s disease; cystic fibrosis
Special Issues, Collections and Topics in MDPI journals
Special Issue in International Journal of Molecular Sciences: Mitochondrial Bioenergetics in Different Pathophysiological Conditions 2.0
Special Issue in International Journal of Molecular Sciences: Mitochondrial Bioenergetics in Different Pathophysiological Conditions 3.0
Special Issue in International Journal of Molecular Sciences: Latest Review Papers in Neurobiology 2023
Special Issue in Oxygen: Mitochondrial Oxidative Stress in Health and Disease
Special Issue Information
Research on mitochondrial function, an indicator of cell health, continues to be fervid.
Mitochondria receive great attention because they emerge as hubs on which cell survival or cell death is ultimately determined. Without ATP from the cell’s powerhouse, cell survival is endangered in neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, epilepsy, stroke, and others. All of these diseases that significantly change the lives of millions of people are characterized by structural, biochemical, or electrical abnormalities in the brain, spinal cord, or other nerves, affecting memory and the ability to perform daily activities.
Morphologic, biochemical, and molecular genetic studies posit that mitochondria constitute a convergence point for these neurological disorders.
The aim of this Special Issue of the International Journal of Molecular Sciences “Mitochondria in Neurological Disorders” is to underline the advances and the most recent discoveries in all fields of science that deal with the role of mitochondria in neurological disorders.
Original full research articles, as well as review articles from research groups all over the world, are welcome in order to disseminate the scientific knowledge on this interesting topic.
Dr. Anna Atlante
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- ROS production
- Mitochondrial DNA
- Alzheimer’s disease
- Parkinson’s disease
- Huntington's disease
- Multiple sclerosis